secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sintx Technologies, Inc. (SINT)
CIK:        0001269026
Form:       8-K
Filed at:   2025-11-13T23:59:59+00:00
Accession:  0001493152-25-022125
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SINTX Q3 2025 net loss narrows to $3.5M; FDA clearance for SINAPTIC wedge system
--------------------------------------------------------------------------------

- Net loss of $3.5M ($1.19 per share) vs $6.2M ($6.96 per share) in Q3 2024.
- Revenue of $0.2M, down from $0.8M YoY due to lower grant revenue; operating expenses decreased 51% to $3.4M.
- Cash rose to $6.25M from $3.60M at Dec 2024; raised $4.3M through warrant exercises.
- FDA 510(k) clearance for SINAPTIC Foot & Ankle Osteotomy Wedge System; first commercial revenue from OsseoSculpt recorded.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1269026/000149315225022125/0001493152-25-022125-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1269026/000149315225022125/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-022125

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer